BridgeBio appeared to be the Corporate Investor, which was created in 2014. The fund was located in North America if to be more exact in United States. The main department of described Corporate Investor is located in the Palo Alto.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 1 or 4 of the founder, the chance for it to be financed is low. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Alternative Medicine. Among the most popular portfolio startups of the fund, we may highlight QED Therapeutics, PellePharm, Eidos Therapeutics.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the BridgeBio, startups are often financed by Third Rock Ventures, Sanofi, Cowen Group. The meaningful sponsors for the fund in investment in the same round are Cormorant Asset Management, Cowen Group, Casdin Capital. In the next rounds fund is usually obtained by Perceptive Life Sciences, LEO Pharma, Cowen Group.
The current fund was established by Neil Kumar.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2018. This BridgeBio works on 11 percentage points more the average amount of lead investments comparing to the other organizations. The fund is constantly included in less than 2 investment rounds annually. Speaking about the real fund results, this Corporate Investor is 20 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2018.
Related Funds
| Fund Name | Location |
| 77 Capital | Japan, Miyagi Prefecture, Sendai |
| ARM Labs | Abuja, Federal Capital Territory, Nigeria |
| Aspen Technology | Bedford, Massachusetts, United States |
| Atlas Peak Capital | California, San Francisco, United States |
| Axis Mutual Fund | India, Maharashtra, Mumbai |
| Beringer Capital | Canada, Ontario, Toronto |
| Binguo Zichan | - |
| Blockchain Investment Group | New York, New York, United States |
| Clickky | New York, New York, United States |
| GGM Capital | Canton Luxembourg, Luxembourg, Münsbach |
| GRID Investments | Brazil, São Paulo, Sao Paulo |
| Haisco | China, Liaoning, Wenxiang |
| Haowo Konggu Jituan | China, Jinan, Shandong |
| North Coast Opportunities Technology Fund | Cleveland, Ohio, United States |
| PS Capital Partners | Milwaukee, United States, Wisconsin |
| RioCan | Canada, Ontario, Toronto |
| SEA Ventures | Pennsylvania, Pittsburgh, United States |
| Timberline Holding | - |
| Yongzhou Capital | - |
| Zhixing Venture Capital | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Eidos Therapeutics | $64M | 05 Apr 2018 | Palo Alto, California, United States | ||
PellePharm | $20M | 01 Aug 2017 | California, United States | ||
MyoKardia | $46M | 30 Apr 2015 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Eidos Therapeutics | $64M | 05 Apr 2018 | Palo Alto, California, United States | ||
PellePharm | $20M | 01 Aug 2017 | California, United States | ||
MyoKardia | $46M | 30 Apr 2015 | California, United States |
